TA
Therapeutic Areas
Clearside Biomedical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CLS-AX (axitinib injectable suspension) | Wet Age-Related Macular Degeneration (AMD) | Phase 3 Ready |
| XIPERE® (triamcinolone acetonide) | Macular Edema Associated with Uveitis | Approved |
| CLS-AX | Diabetic Macular Edema (DME) | Preclinical |